Trial
NCT04822701
A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
COVID-19
Intervention
BI 767551 intravenous
Why stopped
not due to safety reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-28